baber/WOPTO huggingface dataset:
Patent AU-730795-B2 (AU)
Title: Scratch resistant clearcoats containing surface reactive microparticles and method therefore
Inventor: OERMANN BRUCE
IPC: C09D7/61
Filed: 1997-09-29
Granted: 2001-03-15
Abstract: The present invention is a coating composition having good scratch resistance and a method for improving the scratch resistance of a coating composition. The coating composition comprises   (A) a film forming binder system containing a crosslinkable resin and optionally a crosslinking agent for the crosslinkable resin; (B) substantially colorless carbide or inorganic microparticles, range in size from about 1 to 1000 nanometers prior to incorporation in the coating composition, and the microparticles are reactive with the crosslinkable portion of the film forming binder system; (C) a solvent system for the crosslinkable resin, optional crosslinking agent, and microparticles, wherein the crosslinkable resin is present in an amount from about 10 to about 80% by weight and the inorganic microparticles are present in an amount from 0.1 to 60.0 % by weight based on the sum of the weights of the crosslinkable resin, the optional crosslinking agent, and the inorganic microparticles.
Patent AU-735591-B2 (AU)
Title: Transcranial brain stimulation
Inventor: EPSTEIN CHARLES M
IPC: A61N2/02
Filed: 1997-08-15
Granted: 2001-07-12
Abstract: An apparatus and method for transcranial magnetic brain stimulation. The apparatus allows transcranial stimulation at higher power efficiency and lower heat generation than prior available magnetic stimulator coils without an iron core. Use of the apparatus allows an improved method for active localization of language function. The device can also be used in rapid rate transcranial magnetic stimulation for the treatment of depression.
Patent AU-623185-B2 (AU)
Title: Commercial message timer
Inventor: JOHNSON GENE HARLOW
IPC: H04N5/45
Filed: 1989-10-24
Granted: 1992-05-07
Abstract: A commercial message timer (114), when enabled by a user, stores data indicative of a first tuned station and begins timing a predetermined time period. Upon expiration of the time period, the first tuned station is automatically reselected if it had been deselected after the timer was enabled. In this way a user can avoid a commercial message on a first channel by setting the timer and scanning through other channels, and yet have the receiver return automatically to the first channel at the end of a time period substantially equal to that of a typical commercial message. In another embodiment employing PIX-IN-PIX circuity, the subject apparatus is responsive to an occurrence of (1) enabling the timer and (2) changing channels, in that order, for automatically moving the desired channel to the inset position. In response to the expiration of the timer period, the program displayed in the inset position is automatically returned to the main display position.
Patent AU-773187-B2 (AU)
Title: Tumor antigen useful in diagnosis and therapy of prostate and colon cancer
Inventor: AFAR DANIEL E
IPC: C07K16/40
Filed: 1999-06-01
Granted: 2004-05-20
Abstract: Compositions for the diagnosis and therapy of prostate and colon cancer, derived from or based on a novel prostate-specific, androgen-regulated, cell surface serine protease termed 20P1F12/TMPRSS2 are described. A full length cDNA comprising the entire coding sequence of the 20P1F12/TMPRSS2 gene (also designated 20P1F12-GTC1 herein) is provided (FIG. 1 ). Among the compositions provides are antibodies that bind to 20P1F12/TMPRSS2 proteins and polypeptide fragments thereof, including antibodies labeled with a detectable marker or toxin or therapeutic composition. Several monoclonal antibodies specifically reactive with 20P1F12/TMPRSS2 are also described herein.
Patent AU-625323-B2 (AU)
Title: Flexible bar for spectacles and manufacturing method
Inventor: MILONE CARMINE
IPC: G02C5/16
Filed: 1989-11-17
Granted: 1992-07-09
Abstract: The present invention concerns a bar for spectacles formed in two parts of relatively stiff plastic material, joined together by means of an elastic springing element in the form of a spiral spring. According to the invention, said elastic element also comprises a flat spring with surface positioned on a vertical plane, said spiral spring being wound in tight coils around a central part of said flat spring and being checked on opposite sides by two stop rings, the end parts of said flat spring forming means of anchorage into the two bar portions of plastic material. The invention also concerns a method for manufacturing said bars for spectacles, wherein said end parts of the flat spring of the elastic element are enclosed into a respective box of an injection mold, using said stop rings of the elastic element to delimit and close the mold, plastic material being then injected into said boxes to incorporate said end parts of the flat spring.
Patent AU-677956-B2 (AU)
Title: New bacillus thuringiensis strains and their insecticidal proteins
Inventor: LAMBERT BART
IPC: A01N63/50
Filed: 1993-07-12
Granted: 1997-05-15
Abstract: Four novel Bacillus thuringiensis strains, which are deposited at the BCCM-LMG under accession nos. LMG P-12592, LMG P-12593, LMG P-12594, and LMG P-13493, produce new crystal proteins during sporulation that are toxic to Lepidoptera, more particularly against Noctuidae such as Spodoptera spp. and Agrotis ipsilon, against Pyralidae such as Ostrinta nubilalis, and against Yponomeutidae such as Plutella xylostella, and that are encoded by a novel gene. The crystal proteins contain protoxins, which can yield a toxin as trypsin-digestion product. A plant, the genome of which is transformed with a DNA sequence that comes from either one of the strains and that encodes its respective toxin, is resistant to Lepidoptera. Each strain, itself, or its crystals, crystal proteins, protoxin or toxin can be used as the active ingredient in an insecticidal composition for combatting Lepidoptera.
Patent AU-684718-B2 (AU)
Title: Device for sealing hemostatic incisions
Inventor: KATSAROS GEORGES
IPC: A61B17/12
Filed: 1993-07-15
Granted: 1998-01-08
Abstract: A device for sealing incisions in the body of a patient wherein the device includes a bioabsorbable sealing member having an elongate shaft member and an elastomeric and flexible balloon member. The device may also include a preformed or injectable collagenous material associated therewith to hemostatically seal the incision in the body of the patient. The shaft member may include one or more lumens extending therethrough in flow communication with one or more balloon members thereon to provide a relatively simple device which effectively seals an incision in the body of a patient.
Patent AU-695768-B2 (AU)
Title: Device and method for checking patterns disposed on a material strip and the material strip
Inventor: HILMERSSON ANDERS
IPC: G06K19/06
Filed: 1996-02-09
Granted: 1998-08-20
Abstract: Method and device for checking patterns (1) disposed on a material strip (30) which patterns (1) consist of groups of dark and light areas (2,2*,3,3*) succeeding in the travelling direction (v) of the material strip (30) and the checking respectively, by displacing the position of the dark areas (2,3) and/or the light areas (2*,3*) of one group with respect to a related detector (8,9) in regard to the dark areas (2,3) and/or light areas (2*,3*) of another group with respect to another related detector (8,9) by detecting the existence or non-existence of dark areas and/or light areas and by creating a sequence of output signals dependent on the result of the detection by combining the output signals comprising information concerning said dark or light areas (2,2*,3,3*) of each detector (8,9) with the output signals depending on the detection of one of said dark or light areas (2,2*,3,3*) of the other detector (8,9) in a predetermined way by for example alternately activating each detector (8,9) by the other detector (8,9) and by comparing this sequence of output signals with a predetermined sequence of signals.
Patent AU-692364-B2 (AU)
Title: A pipe coupling and a method for securing a pipe to a coupling piece
Inventor: ZEE JAN VAN DER
IPC: F16L21/08
Filed: 1996-02-19
Granted: 1998-06-04
Abstract: A pipe coupling for securing a pipe to a coupling piece, whereby the end of the pipe (1) extends into said coupling piece (2), said pipe coupling being provided with clamping (4), which on the one hand are shaped in such a manner as to engage a correspondingly shaped part of the coupling piece, and which on the other hand clampingly engage said pipe, and being provided with sealing means (3) between said pipe and said coupling piece.
Patent AU-702705-B2 (AU)
Title: Epithelial adhesive lactobacilli
Inventor: ADLERBERTH INGEGERD
IPC: A61K35/747
Filed: 1996-03-25
Granted: 1999-03-04
Abstract: PCT No. PCT/SE96/00372 Sec. 371 Date Sep. 23, 1997 Sec. 102(e) Date Sep. 23, 1997 PCT Filed Mar. 25, 1996 PCT Pub. No. WO96/29083 PCT Pub. Date Sep. 26, 1996The invention refers to the use of Lactobacillus plantarum 299v having a mannose-specific adhesin for the preparation of a pharmaceutical composition inhibiting the binding of pathogenic bacteria expressing mannose-specific adhesins to the epithelial cell surface. The strain of Lactobacillus plantiarum which can be used in the invention adheres to D-mannose-coated agarose beads. The invention also refers to the use of said strain for the preparation of a pharmaceutical composition to be used in prophylatic and/or curative treatment of bacterial translocation, gastroenteritis and other diseases caused by pathogenic bacteria expressing mannose-specific adhesins.
Patent AU-621208-B2 (AU)
Title: Carbonate derivatives of eseroline, a process for their preparation and their use as medicaments
Inventor: GLAMKOWSKI EDWARD J
IPC: A61K31/40
Filed: 1990-03-27
Granted: 1992-03-05
Abstract: This invention relates to 1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethylpyrrolo[2,3-b] indol-5-ol carbonate esters of the formula <CHEM>  where R is lower alkyl, cycloalkyl, aryl, aralkyl or <CHEM> X is hydrogen or halogen; the pharmaceutically acceptable acid addition salts thereof and where applicable to the geometric and optical isomers and racemic mixtures thereof. The compounds of this invention display utility as analgesic agents.
Patent AU-722360-B2 (AU)
Title: Integrin antagonists
Inventor: DUGGAN MARK E
IPC: A61P9/14
Filed: 1997-10-27
Granted: 2000-08-03
Abstract: This invention relates to certain novel compounds and derivatives thereof, their synthesis, and their use as vitronectin receptor antagonists. The vitronectin receptor antagonist compounds of the present invention are  alpha v beta 3 antagonists,  alpha v beta 5 antagonists or dual  alpha v beta 3/ alpha v beta 5 antagonists useful for inhibiting bone resorption, treating and preventing osteoporosis, and inhibiting restenosis, diabetic retinopathy, macular degeneration, angiogenesis, atherosclerosis, inflammation and tumor growth.
Patent AU-762536-B2 (AU)
Title: Method and system for navigating a history list
Inventor: LAPSTUN PAUL
IPC: G06F17/30
Filed: 2000-06-30
Granted: 2003-06-26
Abstract: Provided is a method of collaborative document mark-ups. A first document including first coded data tags is printed. Coded data tags are indicative of an identity unique to the document the tags are printed on and the position of the respective tags on that document. First indicating data is then received from a first sensing device used to mark-up the first document. The first indicating data includes the identity unique to the first document and positions of markings made on the first document using the first sensing device. A first document version including the markings made on the first document is recorded, and a second document including the markings made on the first document and second coded data tags is printed. The process is then repeated with the second document resulting in the recording of a second document version including the markings made on second document linked to the first document version.
Patent AU-747640-B2 (AU)
Title: Overexpression of desired proteins in eukaryotic cells mediated by cyclin D1 overexpression
Inventor: HU SHAW-FEN SYLVIA
IPC: C12N15/67
Filed: 1999-08-11
Granted: 2002-05-16
Abstract: The invention concerns eukaryotic cells useful in protein expression comprising (a) an inserted nucleic acid encoding a cyclin D gene product and (b) an inserted nucleic acid encoding a protein of interest, wherein the cyclin D gene product and the protein of interest are expressed in the cell. The invention also concerns a process for producing a protein of interest, which comprises (a) inserting into a eukaryotic cell a nucleic acid encoding a cyclin D gene product and a nucleic acid encoding a protein of interest; (b) culturing the cell under conditions permitting the expression of the protein of interest; and (c) isolating the protein of interest. The cells are preferably mammalian, with CHO cells most preferred. The cyclin D gene product is preferably of human origin. Suitable proteins of interest include erythropoietin (EPO), osteoprotegerin (OPG), OPG-Fc, leptin, Fc-leptin, and Novel Erythropoiesis Stimulating Protein (NESP).
Patent AU-774252-B2 (AU)
Title: Improved storage and maintenance of blood products including red blood cells and platelets
Inventor: DOTTORI SECONDO
IPC: C12N5/02
Filed: 2000-06-05
Granted: 2004-06-24
Abstract: Cell membrane maintenance of red blood cells and platelet concentrates is improved by the addition of 1 mM-10 mM L-carnitine and derivatives. This improvement allows extension of the period of viability of packed red blood cells and platelet concentrations beyond current periods. Additionally, the materials so treated exhibit extended circulation half life upon transfusion to a patient. Improvements in membrane maintenance achieved by this method permit irradiation of sealed containers of blood products so as to substantially sterilize and destroy leukocytes in the same.
Patent AU-621490-B2 (AU)
Title: High pressure water jet cleaner and coating applicator
Inventor: TAYLOR SIDNEY A
IPC: B08B9/02
Filed: 1990-06-01
Granted: 1992-03-12
Abstract: An automated pipeline rehabilitation apparatus (10) is disclosed. The apparatus employs a centering assembly (24) with pivoting arms (26, 28) which can pivot between an operating position and a installation/removal position to allow the unit to be removed from a pipeline. Arcuate rings (38, 40) are mounted on the arms. Spray nozzles (44) are mounted on the arcuate rings for reciprocating arcuate motion along the rings to treat the pipeline. The nozzles (44) can be used to clean the pipeline and prepare the outer surface of the pipeline with high pressure water jets in training abrasives. The nozzles (44) can also be used to apply a coating, preferably a polyurethane coating to the pipeline.
Patent AU-759223-B2 (AU)
Title: Adhesive labels and manufacture thereof
Inventor: DENNY BARRY
IPC: G09F3/02
Filed: 1999-09-06
Granted: 2003-04-10
Abstract: Adhesive labels are manufactured by cutting windows in an upper layer of a support web (2) through to a lower silicon coated material. Folded leaflets (15) are then adhered by lines of adhesive (11, 12, 13) to the support web (2) and the combination is die-cut to form individual adhesive labels with part of the die-cut folded leaflet extending beyond an edge of a base label formed from the window in the support web. This method of manufacture permits more complex label structures to be constructed without pre-cutting individual base labels.
Patent AU-630208-B2 (AU)
Title: Process for the preparation of an ester of a c22-c40- monocarboxylic acid
Inventor: HEINRICHS FRANZ-LEO
IPC: C07C67/08
Filed: 1990-07-03
Granted: 1992-10-22
Abstract: By esterification of a C22-C40-monocarboxylic acid with alcohols in the presence of an acidic ion exchanger as a catalyst, esters are obtained having a very low metal ion content, low conductivity and very good heat and colour stability.
Patent AU-594355-B2 (AU)
Title: Production of molten pig iron and manufacture of gas
Inventor: AXELSSON CARL LENNART
IPC: C21B11/00
Filed: 1986-07-11
Granted: 1990-03-08
Abstract: A method for producing raw iron from iron-bearing oxidic material, comprising finally reducing the iron oxide by charging the iron oxide, coal, oxygen gas and slag-forming flux to a molten iron bath contained in at least one reactor vessel, a final reduction reactor (2), for final reduction of the iron oxide, and pre-reducing primarily non reduced iron oxide in a pre-reduction stage (1), and subsequently charging the pre-reduced iron oxide to the reactor, and generating reduction gas (17) for the afore-said pre-reduction process. The method is particularly characterized in that the reduction gas for the pre-reduction process (1) is generated by a separate gas generating process (3) effected in at least one reactor (3), a gas generating reactor, separate from the final reduction reactor or reactors (2). The invention also relates to a plant for carrying out the method.
Patent AU-642661-B2 (AU)
Title: A process for the purification of plasminogen activator inhibitor 2 (PAI-2)
Inventor: RADTKE KLAUS-PETER
IPC: C07K14/81
Filed: 1990-09-05
Granted: 1993-10-28
Abstract: Purification of plasminogen activator inhibitor 2 (I) comprises (1) pre-incubating (I)-contg. soln. with an agent (A) for splitting disulphide bridges (2) treating with a water-soluble acridine or quinoline base (pref. 2-ethoxy-6,9-diaminoacridine lactate (II)) so that the ppte. formed contains little or no (I), (3) sepn. of this ppte. and (4) recovery of (I) from the supernatant and opt. further purification by known methods. (A) is pref. dithiothreitol (DTT) used at a concn. of 10-250 (pref. 100) mM, and preincubation is for 0.25-3 (esp. 1) hr. at 10-40 (pref. 37 deg.C). The starting soln. is pref. placental extract or contains (I) made by recombinant DNA methods, and after incubation with DTT is treated with (II) at 0.2-2g/g protein in soln. at pH 5.5-8.5. The resulting supernatant (which contains 85-90% of the (I) but only 5-8% of total proteins) can be treated with 5% NaCl to salt out (II), then subjected to pptn. with (NH4) S04 (a) at 30% satn. to remove more impurities and (b) at 80% satn. to recover (I). (I) is used therapeutically to regulate the fibrinolytic system. Compared with known methods for purifying (I) (which involve 8 stages) this process is simpler and is suitable for large scale operation. The base pptes. impurities while (I) remains in soln.
Patent AU-705146-B2 (AU)
Title: Bolt unit and frame arrangement
Inventor: KIBBLE ANTHONY WILFRED
IPC: E05B17/20
Filed: 1996-06-26
Granted: 1999-05-13
Abstract: PCT No. PCT/GB96/01530 Sec. 371 Date Dec. 24, 1997 Sec. 102(e) Date Dec. 24, 1997 PCT Filed Jun. 26, 1996 PCT Pub. No. WO97/01690 PCT Pub. Date Jan. 16, 1997This invention relates to a bolt unit and frame arrangement. In particular it relates to a lockable bolt unit having a slidable bolt, typically for securing two moveable panels together or for securing one moveable panel to a fixed frame.
Patent AU-779116-B2 (AU)
Title: Therapeutic compounds comprised of anti-Fc receptor binding agents
Inventor: DEO YASHWANT M
IPC: C07K19/00
Filed: 2000-07-25
Granted: 2005-01-06
Abstract: Multispecific molecules which induce effector cell-mediated killing of target cells are disclosed. The molecules are "multispecific" because they bind to multiple (two or more), distinct targets, one of which is an Fc receptor on the surface of an immune cell. Multispecific molecules of the invention include molecules comprised of at least one portion which binds to an Fc receptor, such as an Fc gamma  receptor (e.g., Fc gamma RI) or an Fc alpha  receptor, and at least one other portion which binds to a different target, such as an antigen on a tumor cell or a pathogen. Multispecific molecules of the invention also include antigen "multimer complexes" comprised of multiple (i.e., two or more) portions which bind to a molecule on an antigen presenting cell (APC), such as an Fc receptor, linked to one or more antigens. These multimer complexes target antigens, such as self-antigens, to APCs to induce and/or enhance internalization (endocytosis), processing and/or presentation of the antigen by the APC. Therefore, these molecules can be used to induce or enhance an immune response either <i>in vivo</i> or <i>in vitro</i> against a normally non-immunogenic protein, such as a self-antigen. In a particular embodiment, at least one portion of the multispecific molecules comprises a humanized or human antibody or antibody fragment (e.g., ScFv or Fab') which binds to an Fc receptor or a receptor on a target cell (e.g., EGF-R or HER2).
Patent AU-729513-B2 (AU)
Title: A sample presentation apparatus for mass spectrometry
Inventor: NELSON RANDALL W
IPC: C12N11/00
Filed: 1996-06-06
Granted: 2001-02-01
Abstract: A sample presentation device, with a surface-bound complex including at least one molecule which chemically modifies a biomolecule, is prepared and exposed to a biomolecule. The molecular weight of the chemically modified biomolecule is then determined by mass spectrometry.
Patent AU-638060-B2 (AU)
Title: Edible spread
IPC: A01J17/00
Filed: 1990-10-09
Granted: 1993-06-17
Abstract: Edible spreads are prone to microbiological spoilage by a number of organisms, including molds and bacteria as well as by physical changes occurring on storage. While the growth of these organisms and consequently the onset of spoilage can be inhibited by the use of preservatives, some consumers find preservatives unacceptable. We have determined that in edible fat products wherein the fat phase comprise a homogeneous dispersion of fine crystals and in which the fat phase is essentially free of crystalline aggregates spoilage is greatly reduced. Anhydrous products can be produced by melting the fat, substantially in the absence of an aqueous medium, cooling the melted fat to a temperature at which partial crystallization occurs, homogenising the partially crystallised fat, and, cooling the homogenised fat to further crystallise the fat. By means of a modified process it is possible to produce comprising 50-60% fat phase, 40-50% water phase, 0.1-1% lecithin, 0.01-1% salt, being essentially free of monoglycerides, proteins and sorbate salts, which are stable on storage.
Patent AU-643484-B2 (AU)
Title: Data disc and method for retrieving data recorded on data disc
Inventor: SASAKI NORIMASA
IPC: G11B23/36
Filed: 1991-01-04
Granted: 1993-11-18
Abstract: An optical data disc recorded to a CD-standard on which a volume descriptor, route directory and files are stored. A file includes main text data, a plurality of indices for the main text data and literature supervising data. The literature supervising data is arranged in the leading position of the file and includes address data of the plurality of indices. A list of indices can be displayed easily, allowing an index to be selected. The selected index can then be readily found using the stored address data. <IMAGE>